Annual Net Margin
-139.70%
+55.01%+28.25%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual net profit margin is -139.70%, with the most recent change of +55.01% (+28.25%) on December 31, 2023.
- During the last 3 years, RARE annual net margin has fallen by -70.86% (-102.93%).
- RARE annual net margin is now -102.93% below its all-time high of -68.84%, reached on December 31, 2020.
Performance
RARE Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-95.71%
-6.20%-6.93%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly net profit margin is -95.71%, with the most recent change of -6.20% (-6.93%) on September 30, 2024.
- Over the past year, RARE quarterly net margin has increased by +67.11% (+41.22%).
- RARE quarterly net margin is now -333.33% below its all-time high of 41.02%, reached on June 30, 2020.
Performance
RARE Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
RARE Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.3% | +41.2% |
| 3 y3 years | -102.9% | -7.0% |
| 5 y5 years | +63.6% | +78.2% |
RARE Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.1% | +28.3% | -6.9% | +64.6% |
| 5 y | 5-year | -102.9% | +64.0% | -333.3% | +70.8% |
| alltime | all time | -102.9% | +99.9% | -333.3% | +100.0% |
Ultragenyx Pharmaceutical Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -95.71%(+6.9%) |
| Jun 2024 | - | -89.51%(-42.9%) |
| Mar 2024 | - | -156.83%(+62.2%) |
| Dec 2023 | -139.70%(-28.3%) | -96.70%(-40.6%) |
| Sep 2023 | - | -162.82%(+10.3%) |
| Jun 2023 | - | -147.57%(-9.6%) |
| Mar 2023 | - | -163.16%(+11.1%) |
| Dec 2022 | -194.71%(+50.7%) | -146.91%(-45.6%) |
| Sep 2022 | - | -270.23%(+52.6%) |
| Jun 2022 | - | -177.03%(-7.1%) |
| Mar 2022 | - | -190.55%(+29.8%) |
| Dec 2021 | -129.20%(+87.7%) | -146.85%(+64.2%) |
| Sep 2021 | - | -89.41%(-36.5%) |
| Jun 2021 | - | -140.76%(+2.8%) |
| Mar 2021 | - | -136.97%(+422.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | -68.84%(-82.3%) | -26.23%(-69.0%) |
| Sep 2020 | - | -84.50%(-306.0%) |
| Jun 2020 | - | 41.02%(-112.5%) |
| Mar 2020 | - | -327.81%(+24.4%) |
| Dec 2019 | -388.31%(+1.2%) | -263.55%(-39.8%) |
| Sep 2019 | - | -437.96%(+6.6%) |
| Jun 2019 | - | -410.67%(-22.9%) |
| Mar 2019 | - | -532.45%(-1.4%) |
| Dec 2018 | -383.75%(-96.7%) | -540.10%(-27.2%) |
| Sep 2018 | - | -742.24%(+80.1%) |
| Jun 2018 | - | -412.13%(-87.8%) |
| Dec 2017 | -11.57 K%(-93.7%) | -3385.71%(-91.5%) |
| Sep 2017 | - | -40.01 K%(-97.2%) |
| Dec 2016 | -184.87 K% | -1.43 M%(+2338.2%) |
| Sep 2016 | - | -58.47 K%(-82.5%) |
| Jun 2016 | - | -334.84 K% |
FAQ
- What is Ultragenyx Pharmaceutical annual net profit margin?
- What is the all time high annual net margin for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual net margin year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly net profit margin?
- What is the all time high quarterly net margin for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly net margin year-on-year change?
What is Ultragenyx Pharmaceutical annual net profit margin?
The current annual net margin of RARE is -139.70%
What is the all time high annual net margin for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual net profit margin is -68.84%
What is Ultragenyx Pharmaceutical annual net margin year-on-year change?
Over the past year, RARE annual net profit margin has changed by +55.01% (+28.25%)
What is Ultragenyx Pharmaceutical quarterly net profit margin?
The current quarterly net margin of RARE is -95.71%
What is the all time high quarterly net margin for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly net profit margin is 41.02%
What is Ultragenyx Pharmaceutical quarterly net margin year-on-year change?
Over the past year, RARE quarterly net profit margin has changed by +67.11% (+41.22%)